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Abstract 
Background: To determine the frequency of 
Vitamin D insufficiency in patients with breast 
cancer. 
Methods: In this comparative study diagnosed 
cases of carcinoma breast (n=50) were enrolled. 
Equal number were taken as control. Patients 
undergoing current dialysis treatment, elevated liver 
enzymes, primary hyperparathyroidism, 
hypercalcemia, hypercalciuria, or Paget’s disease and 
already taking therapy to improve vitamin D levels 
were excluded. Vitamin D levels were measured by 
Enzyme Linked Immunosorbant Assay(ELISA).Chi 
square test was applied to compare the vitamin D 
deficiency in cases and controls. Odds ratio were 
calculated. Stratification was done for duration of 
disease (in months) age of patients, family history to 
control the effect modifier. 
Results: In our study, 64%(n=32) in cases and 
100%(n=50) in controls were between 25-45 years of 
age while 36%(n=18) in cases group were between 
46-65 years of age, Mean+SD was calculated as 
40.60+10.02 and 32.08+4.12 respectively.Frequency of 
vitamin D deficiency was 92% in cases and 63% in 
controls.  
Conclusion: Fequency of Vitamin D insufficiency 
in patients with breast cancer was significantly 
higher as compared to the controls. Dietary vitamin 
D and casual sunlight exposure may be among the 
modifiable risk factors for breast cancer. 
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Introduction 
     With one million new cases in the world each year, 
breast cancer is the most common malignancy in 
women and comprises 18% of all female cancers.1 In 
Pakistan this morbidity is recorded most commonly 
in younger age women as compared to the Western 
countries where it is more common in older age 
women.2 Highest frequencies of breast cancer have 
been noted in Pakistani women compared to other 
Asian countries.3 
    There is a growing interest in identifying the relative 
importance of environmental, lifestyle and dietary 
factors, and how these may interact with genetic 
susceptibility to modify risk of the disease. There is 
increasing evidence for a link between vitamin D and 
protection against breast cancer.4 The link between 
vitamin D levels and lower breast cancer risk was 
initially suggested by investigators reporting a 
correlation between greater sunlight exposure (higher 
vitamin D levels) and lower rates of breast 
cancer.5Prevalence of vitamin D insufficiency in breast 
cancer varies among different populations.6,7   Vitamin 
D insufficiency was seen in 95.6% breast cancer 
patients in Shaukat Khanum Memorial Hospital 
Lahore9. Studies from United States report 50-74% 
vitamin D insufficiency in breast cancer 
patients10.Another study from the St. Louis 
metropolitan area and neighboring counties showed 
that 78% of the breast cancer patients were vitamin D 
deficient11. In Saudia Arabia 60.8%  and in Chinese 
population 96.1% breast cancer patients have 
insufficient Vitamin D levels.12,13 
  
Patients and Methods 
In this comparative study, performed in Department 
of Surgery, Unit II,Holy Family Hospital, Rawlapindi, 
from July 2013 to January 2014, diagnosed cases of 
carcinoma breast (n=50) were enrolled . Equal number 
were taken as control. Patients undergoing current 
dialysis treatment, elevated liver enzymes, primary 
hyperparathyroidism, hypercalcemia, hypercalciuria, 
or Paget’s disease and already taking therapy to 
improve vitamin D levels were excluded. Vitamin D 
levels were measured by Enzyme Linked 
Immunosorbant Assay(ELISA).Chi square test was 
applied to compare the vitamin D deficiency in cases 
and controls. Odds ratio were calculated. Stratification 
was done for duration of disease (in months) age of 
patients, family history to control the effect modifier. 
 
Results 
    Age distribution showed  that 64%(n=32) in cases 
and 100%(n=50) in controls were between 25-45 years 
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of age(Table 1). Frequency of vitamin D deficiency 
was  92 %in cases and 62 % in controls(Table 2).  
Table 1: Carcinoma Breast -Age distribution(n=100) 
Age 
(in years) 
Cases(n=50) Controls(n=50) 
No % Nos % 
25-45 32 64 50 100 
46-65 18 36 00 00 
Total 50 
10
0 
50 100 
Mean+SD 40.60+10.02 32.08+4.12 
Table 2:  Carcinoma breast -Frequency of 
vitamin D deficiency(n=100) 
Vitamin D Deficiency CA Breast 
No(%) 
Controls 
No(%) 
Vitamin D Deficient  46(92) 31 (62) 
Vitamin D  Normal  4(8) 19(38) 
Total 50 50 
Odds Ratios: 7.0484  p- value: 0.0011 
 
Table  3:Carcinoma breast - stratification for age 
(n=77) 
Age 
(in years) 
Controls (n=31) 
No (%) No (%) 
25-45 30(65.22) 31 (100) 
46-65 16(34.78) 00 (00) 
Table 4:Carcinoma Breast -stratification for 
duration  of disease(n=77) 
Duration of disease 
(in months) 
Cases (n=46) 
Yes No 
1-6 21 25 
>6 25 21 
   Vitamin D deficiency was stratified in both groups 
according to age which showed that out of 46 patients 
in cases group 65.22%(n=30) were between 25-45 years 
and 34.78%(n=16) were between 34.78%(n=16) were 
between 46-65 years of age, while out of 31 patients 
100%(n=31) in control group were between 25-45 years 
of age (Table  3). Out of 46 patients in cases group 21 
were between 1-6 months of duration of disease while 
remaining 25 had >6 months of duration of 
disease.(Table  4) 
 
Discussion 
 The role of vitamin D in relation to breast 
cancer incidence and outcome is controversial. 
Evidence from in vitro studies, and selected clinical 
observational studies  has generally supported an 
association between higher vitamin D intakes and 
levels with lower breast cancer risk, but the results 
have not been consistent.14-17  Present study findings 
are in accordance with a study where Vitamin D 
deficiency was seen in 95.6% breast cancer patients in 
Shaukat Khanum Memorial Hospital Lahore and with 
a study in Chinese population in which 96.1% breast 
cancer patients had insufficient Vitamin D levels.13 
        Results of present study are in contrast with the 
studies from United States reporting  50-74% vitamin 
D deficiency in breast cancer patients.10 Another study 
from the St. Louis Metropolitan Area and 
neighbouring counties showed that 78% of the breast 
cancer patients were vitamin D deficient.11 
Neuhouseret al and Waltmanet al found insufficiency 
rates of 75.6% and 86%, respectively. 18,19 
     Present study has limitations. First, sun exposure 
was not explicitly measured. A single, cross-sectional 
vitamin D serum concentration was drawn per 
participant after diagnosis and treatment due to 
funding constraints. No power calculation was 
performed because of the limited resources outlined 
earlier. Limitations are inherent in the use of food 
frequency questionnaires to capture all food intake 
and discrepancies in self-reported intake.These 
limitations were tried to be controlled through a 
control group, which shows a significant higher 
frequency of vitamin D deficiency. 
 Vitamin D deficiency appeared to be prevalent 
among both groups, while assessment of Vitamin D 
status should be part of a regular nutrition assessment 
for most women. It is unlikely that increasing vitamin 
D intake from food would be an effective method of 
preventing vitamin D deficiency due to the large 
amounts of food that would have to be eaten on a 
daily basis.  
 
Conclusion 
1. Frequency of Vitamin D insufficiency in patients 
with breast cancer is significantly higher as 
compared to the controls.  
2. Dietary vitamin D and casual sunlight exposure 
may be among the modifiable risk factors for 
breast cancer. 
 
References 
 
1. Butt Z, Haider SF, Arif S, Khan MR, Ashfaq U..Breast cancer 
risk factors: A comparison between pre-menopausaland 
post-menopausal women.JPMA 2012; 62:120-23. 
Journal of Rawalpindi Medical College (JRMC); 2014;18(2):199-201 
 
 201 
2. Naeem M, Khan N, Aman Z, Nasir A, Samad A. Pattern of 
breast cancer:Experience at lady reading hospital, Peshawar. 
JAMC 2008; 20(4):22-25. 
3. Faheem M, Khurram M, Jafri IA, Mehmood H, Hasan Z. Risk 
factors for breast cancer in patients treated at NORI Hospital, 
Islamabad. JPMA 2007; 57:242-44. 
4. Colston KW. Vitamin D and breast cancer risk. Best Pract Res 
Clin End Met 2008; 22:587–99. 
5. Stephanie L, Hines H, Keels S, Kristine M. Breast cancer 
survivors and vitamin D: A review. Nutrition 2010; 26; 255–
62. 
6. Shao T, Klein P, Grossbard ML. Vitamin D and breast cancer. 
Oncologist. 2012; 17(1):36-45. 
7. Trukova KP, Grutsch J, Lammersfeld C, Liepa G. Prevalence 
of vitamin D insufficiency among breast cancer survivors. 
NutrClinPract. 2012; 27(1):122-28. 
8. Chen P, Hy P, Xie D, Qin Y, Wang F. Meta-analysis of 
vitamin D, calcium and the prevention of breast cancer. 
Breast Cancer Res Treat 2010;121:469-77 
9. Imtiaz S, Siddiqui N, Raza SA, Loya A, Mohammad A. 
Vitamin D deficiency in newly diagnosed breast cancer 
patients : Indian J Endocrine Metab 2012:16;409-13 
10. Khan QJ and  Fabian CJ. How I treat vitamin D Deficiency. 
JOP. 2010; 6:97–100.  
11. High prevalence of low vitamin D and musculoskeletal 
complaints in patients with breast cancer : 
PMCID: PMC3689648 
12. Yousef FM, Jacobs ET, Kang PT. Deptt of Nutritional Sciences, 
University of Arizona, USA. Vitamin D status and breast 
cancer in Saudi Arabian women: pmc:23697705 
13. Peizhan Chen, Mian Li, XiaoliGu.  Higher Blood 25(OH)D 
Level May Reduce the Breast Cancer Risk. PLoS One. 2013; 
8(1):e49312. 
14. Deeb KK, Trump DL, Johnson CS: Vitamin D signaling 
pathways in cancer: potential for anticancer therapeutics. 
Nat Rev Cancer 2007; 7:684-700. 
15. James SY, Mackay AG, Colston KW. Effects of 
1,25dihydroxyvitamin D3 and its analogues on induction of 
apoptosis in breast cancer cells. J Steroid Biochem MolBiol 
1996; 58:395-401. 
16. John EM, Schwartz GG, Dreon DM, Koo J. Vitamin D and 
breast cancer risk :the NHANES I Epidemiologic follow-up 
study, 1971–1975 to 1992.National Health and Nutrition 
Examination Survey. Cancer EpidemiolBiomarkers Prev 
1999; 8:399-406. 
17. Garland CF, Gorham ED, Mohr SB, Garland FC: Vitamin D 
and cancerprevention: global perspective. Ann Epidemiol 
2009; 19:468-83. 
18. Neuhouser ML, Sorensen B, Hollis BW. Vitamin D 
insufficiency in a multiethnic cohort of breast cancer 
survivors. Am J ClinNutr 2008;88:133-39 
19. Waltman NL, Ott CD, Twiss JJ, Gross GH, Lindsey AM. 
Vitamin D insufficiency and musculoskeletal symptoms in 
breast cancer survivors on aromatase inhibitor therapy. 
Cancer Nurs. 2009;32:143-50.. 
 
